Label Image For 30mg (Nifedipine Er 30mg)
Nifedipine
Product Images NDC 53808-1118
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Nifedipine (NDC 53808-1118). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Doh Central Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image1 (Image 01)
Image2 (Image 02)
MEAN REDUCTIONS IN TROUGH SUPINE BLOOD PRESSURE (mmHg) for Nifedipine ER extended-release tablets at different doses (30mg, 60mg, 90mg) reported in two studies. Study 1 shows reductions in systolic/diastolic pressures with doses of 30mg, 60mg, and 90mg. Study 2 also presents reductions in systolic/diastolic pressures with doses of 30mg, 60mg, and 90mg. The text also clarifies that Nifedipine ER is Nifedipine extended-release tablets.*
Image3 (Image 03)
This is a table showing the percentage of patients experiencing certain adverse effects while taking nifedipine extended-release tablets compared to a placebo. The adverse effects include headache, flushing/heat sensation, dizziness, fatigue/asthenia, nausea, and constipation. The number of patients (n) included in the study for each group is also provided.*
Image4 (Image 04)
These are Novast strength color markings for different dosages: 30 mg (yellow color with "Novast" on one side and "33" on the other), 60 mg (pink color with "Novast" on one side and "36" on the other), and 90 mg (brown color with "Novast" on one side and "39" on the other).*
Image6 (Image 06)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
